Skip to main content

Table 1 Patient baseline characteristics

From: Intravenous anidulafungin followed optionally by oral voriconazole for the treatment of candidemia in Asian patients: results from an open-label Phase III trial

Baseline characteristic (n = 43)
Age, years  
  18–44 10
  45–64 15
  ≥ 65 18
  Mean ± SD 56.5 (± 18.5)
  Range 19–91
Gender, % of patients  
  Male 53.5
  Female 46.5
Race, n (%)  
  Asian 43 (100)
Weighta, kg  
  Mean ± SD 57.5 (± 12.2)
  Range 32.0–84.0
Heightb, cm  
  Mean ± SD 162.4 (± 7.4)
  Range 148.0–180.0
Baseline pathogenc, n (%)  
  Candida tropicalis 18 (41.9)
  C. albicans 14 (32.6)
  C. glabrata 6 (14.0)
  C. parapsilosis 4 (9.3)
  C. rugosa 1 (2.3)
  No pathogen isolated 1 (2.3)
  1. aData available from 41 patients.
  2. bData available from 38 patients.
  3. cPatients could have more than one pathogen isolated at baseline.
  4. Abbreviation used: SD, standard deviation.